Upgrades
Keefe, Bruyette & Woods upgraded the previous rating for Progressive Corp (NYSE:PGR) from Underperform to Market Perform. For the first quarter, Progressive had an EPS of $1.11, compared to year-ago quarter EPS of $1.73. The current stock performance of Progressive shows a 52-week-high of $121.36 and a 52-week-low of $89.35. Moreover, at the end of the last trading period, the closing price was at $109.75.
According to Noble Capital Markets, the prior rating for Indonesia Energy Corp Ltd (AMEX:INDO) was changed from Market Perform to Outperform. NoneAt the moment, the stock has a 52-week-high of $86.99 and a 52-week-low of $2.61. Indonesia Energy Corp closed at $6.85 at the end of the last trading period.
For Middlesex Water Co (NASDAQ:MSEX), Janney Montgomery Scott upgraded the previous rating of Neutral to Buy. In the first quarter, Middlesex Water showed an EPS of $0.68, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.42 and a 52-week-low of $75.77. Middlesex Water closed at $84.39 at the end of the last trading period.
According to Janney Montgomery Scott, the prior rating for American Water Works Co Inc (NYSE:AWK) was changed from Neutral to Buy. American Water Works earned $0.87 in the first quarter, compared to $0.73 in the year-ago quarter. At the moment, the stock has a 52-week-high of $189.65 and a 52-week-low of $129.45. American Water Works closed at $144.58 at the end of the last trading period.
Cantor Fitzgerald upgraded the previous rating for Aurora Cannabis Inc (NASDAQ:ACB) from Neutral to Overweight. Aurora Cannabis earned $0.33 in the third quarter, compared to $0.67 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.54 and a 52-week-low of $1.21. Aurora Cannabis closed at $1.42 at the end of the last trading period.
Mizuho upgraded the previous rating for Sunoco LP (NYSE:SUN) from Neutral to Buy. Sunoco earned $2.32 in the first quarter, compared to $1.60 in the year-ago quarter. The current stock performance of Sunoco shows a 52-week-high of $46.95 and a 52-week-low of $34.26. Moreover, at the end of the last trading period, the closing price was at $36.23.
According to Wells Fargo, the prior rating for Becton, Dickinson and Co (NYSE:BDX) was changed from Equal-Weight to Overweight. Becton, Dickinson earned $3.18 in the second quarter, compared to $3.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $280.62 and a 52-week-low of $231.46. Becton, Dickinson closed at $242.54 at the end of the last trading period.
Goldman Sachs upgraded the previous rating for Wolfspeed Inc (NYSE:WOLF) from Neutral to Buy. For the third quarter, Wolfspeed had an EPS of $0.12, compared to year-ago quarter EPS of $0.22. The stock has a 52-week-high of $142.33 and a 52-week-low of $58.07. At the end of the last trading period, Wolfspeed closed at $62.90.
According to Morgan Stanley, the prior rating for Altria Group Inc (NYSE:MO) was changed from Underweight to Equal-Weight. For the first quarter, Altria Group had an EPS of $1.12, compared to year-ago quarter EPS of $1.07. At the moment, the stock has a 52-week-high of $57.05 and a 52-week-low of $41.00. Altria Group closed at $42.51 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
Citigroup downgraded the previous rating for Coterra Energy Inc (NYSE:CTRA) from Buy to Neutral. For the first quarter, Coterra Energy had an EPS of $1.01, compared to year-ago quarter EPS of $0.37. At the moment, the stock has a 52-week-high of $36.55 and a 52-week-low of $14.28. Coterra Energy closed at $25.90 at the end of the last trading period.
For Continental Resources Inc (NYSE:CLR), Citigroup downgraded the previous rating of Buy to Neutral. Continental Resources earned $2.65 in the first quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Continental Resources shows a 52-week-high of $75.49 and a 52-week-low of $31.40. Moreover, at the end of the last trading period, the closing price was at $64.22.
Citigroup downgraded the previous rating for Hess Corp (NYSE:HES) from Buy to Neutral. For the first quarter, Hess had an EPS of $1.30, compared to year-ago quarter EPS of $0.82. The current stock performance of Hess shows a 52-week-high of $131.44 and a 52-week-low of $61.93. Moreover, at the end of the last trading period, the closing price was at $99.36.
According to Citigroup, the prior rating for Marathon Oil Corp (NYSE:MRO) was changed from Buy to Neutral. For the first quarter, Marathon Oil had an EPS of $1.02, compared to year-ago quarter EPS of $0.21. The current stock performance of Marathon Oil shows a 52-week-high of $33.23 and a 52-week-low of $10.41. Moreover, at the end of the last trading period, the closing price was at $22.02.
According to Wells Fargo, the prior rating for Baxter International Inc (NYSE:BAX) was changed from Overweight to Equal-Weight. For the first quarter, Baxter Intl had an EPS of $0.93, compared to year-ago quarter EPS of $0.76. The current stock performance of Baxter Intl shows a 52-week-high of $89.70 and a 52-week-low of $63.25. Moreover, at the end of the last trading period, the closing price was at $65.08.
For Denny's Corp (NASDAQ:DENN), Wedbush downgraded the previous rating of Outperform to Neutral. In the first quarter, Denny's showed an EPS of $0.11, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $17.42 and a 52-week-low of $8.51. At the end of the last trading period, Denny's closed at $8.90.
Goldman Sachs downgraded the previous rating for Ameriprise Financial Inc (NYSE:AMP) from Buy to Neutral. For the first quarter, Ameriprise Financial had an EPS of $5.98, compared to year-ago quarter EPS of $5.43. The stock has a 52-week-high of $332.37 and a 52-week-low of $233.16. At the end of the last trading period, Ameriprise Financial closed at $239.56.
For H.B. Fuller Co (NYSE:FUL), JP Morgan downgraded the previous rating of Neutral to Underweight. H.B. Fuller earned $1.11 in the second quarter, compared to $0.94 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.73 and a 52-week-low of $57.60. H.B. Fuller closed at $59.24 at the end of the last trading period.
Evercore ISI Group downgraded the previous rating for 8x8 Inc (NYSE:EGHT) from Outperform to Neutral. In the fourth quarter, 8x8 showed an EPS of $0.05, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $28.68 and a 52-week-low of $5.18. At the end of the last trading period, 8x8 closed at $5.78.
For Futu Holdings Ltd (NASDAQ:FUTU), JP Morgan downgraded the previous rating of Overweight to Neutral. In the first quarter, Futu Holdings showed an EPS of $0.53, compared to $1.03 from the year-ago quarter. The current stock performance of Futu Holdings shows a 52-week-high of $181.44 and a 52-week-low of $21.23. Moreover, at the end of the last trading period, the closing price was at $52.42.
For Assurant Inc (NYSE:AIZ), Piper Sandler downgraded the previous rating of Overweight to Neutral. Assurant earned $3.75 in the first quarter, compared to $2.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $194.12 and a 52-week-low of $144.18. Assurant closed at $169.31 at the end of the last trading period.
According to SVB Leerink, the prior rating for F-star Therapeutics Inc (NASDAQ:FSTX) was changed from Outperform to Market Perform. For the first quarter, F-star Therapeutics had an EPS of $0.57, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $9.52 and a 52-week-low of $2.07. F-star Therapeutics closed at $6.36 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
For Inter & Co Inc (NASDAQ:INTR), Goldman Sachs initiated coverage, by setting the current rating at Sell. The stock has a 52-week-high of $4.00 and a 52-week-low of $3.47. At the end of the last trading period, Inter & Co closed at $3.48.
With an Outperform rating, Evercore ISI Group initiated coverage on Bausch & Lomb Corp (NYSE:BLCO). The price target seems to have been set at $21.00 for Bausch & Lomb. Bausch & Lomb earned $0.24 in the first quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $20.20 and a 52-week-low of $13.17. At the end of the last trading period, Bausch & Lomb closed at $15.51.
For Amyris Inc (NASDAQ:AMRS), JP Morgan initiated coverage, by setting the current rating at Neutral. In the first quarter, Amyris showed an EPS of $0.37, compared to $0.35 from the year-ago quarter. The current stock performance of Amyris shows a 52-week-high of $17.42 and a 52-week-low of $1.47. Moreover, at the end of the last trading period, the closing price was at $2.15.
Cowen & Co. initiated coverage on Biote Corp (NASDAQ:BTMD) with an Outperform rating. The price target for Biote is set to $11.00. The current stock performance of Biote shows a 52-week-high of $7.25 and a 52-week-low of $3.25. Moreover, at the end of the last trading period, the closing price was at $3.45.
Raymond James initiated coverage on Cano Health Inc (NYSE:CANO) with an Outperform rating. The price target for Cano Health is set to $8.00. The stock has a 52-week-high of $15.58 and a 52-week-low of $3.81. At the end of the last trading period, Cano Health closed at $4.81.
Cowen & Co. initiated coverage on Marathon Digital Holdings Inc (NASDAQ:MARA) with a Market Perform rating. The price target for Marathon Digital Holdings is set to $7.00. Marathon Digital Holdings earned $0.02 in the first quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $83.45 and a 52-week-low of $6.12. Marathon Digital Holdings closed at $7.05 at the end of the last trading period.
Seaport Global initiated coverage on Caleres Inc (NYSE:CAL) with a Buy rating. The price target for Caleres is set to $35.00. For the first quarter, Caleres had an EPS of $1.32, compared to year-ago quarter EPS of $0.60. The current stock performance of Caleres shows a 52-week-high of $29.94 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $26.67.
BTIG initiated coverage on Agilon Health Inc (NYSE:AGL) with a Neutral rating. For the first quarter, Agilon Health had an EPS of $0.00, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $42.98 and a 52-week-low of $14.36. Agilon Health closed at $22.46 at the end of the last trading period.
With a Buy rating, Jefferies initiated coverage on SpringBig Holdings Inc (NASDAQ:SBIG). The price target seems to have been set at $4.50 for SpringBig Holdings. The current stock performance of SpringBig Holdings shows a 52-week-high of $5.44 and a 52-week-low of $2.25. Moreover, at the end of the last trading period, the closing price was at $2.51.
Barclays initiated coverage on Iron Mountain Inc (NYSE:IRM) with an Overweight rating. The price target for Iron Mountain is set to $58.00. In the first quarter, Iron Mountain showed an EPS of $0.38, compared to $0.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.61 and a 52-week-low of $41.67. Iron Mountain closed at $47.95 at the end of the last trading period.
Cowen & Co. initiated coverage on Core Scientific Inc (NASDAQ:CORZ) with an Outperform rating. The price target for Core Scientific is set to $3.10. At the moment, the stock has a 52-week-high of $11.49 and a 52-week-low of $1.91. Core Scientific closed at $2.05 at the end of the last trading period.
BMO Capital initiated coverage on Y-mAbs Therapeutics Inc (NASDAQ:YMAB) with an Outperform rating. The price target for Y-mAbs Therapeutics is set to $27.00. Y-mAbs Therapeutics earned $0.64 in the first quarter, compared to $0.75 in the year-ago quarter. The current stock performance of Y-mAbs Therapeutics shows a 52-week-high of $39.82 and a 52-week-low of $6.50. Moreover, at the end of the last trading period, the closing price was at $14.68.
BMO Capital initiated coverage on CytomX Therapeutics Inc (NASDAQ:CTMX) with an Outperform rating. The price target for CytomX Therapeutics is set to $9.00. For the first quarter, CytomX Therapeutics had an EPS of $0.37, compared to year-ago quarter EPS of $0.26. The current stock performance of CytomX Therapeutics shows a 52-week-high of $7.53 and a 52-week-low of $1.50. Moreover, at the end of the last trading period, the closing price was at $1.87.
BMO Capital initiated coverage on Exelixis Inc (NASDAQ:EXEL) with an Outperform rating. The price target for Exelixis is set to $28.00. Exelixis earned $0.26 in the first quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $23.52 and a 52-week-low of $15.50. At the end of the last trading period, Exelixis closed at $21.33.
BMO Capital initiated coverage on Nuvalent Inc (NASDAQ:NUVL) with an Outperform rating. The price target for Nuvalent is set to $28.00. For the first quarter, Nuvalent had an EPS of $0.36, compared to year-ago quarter EPS of $2.20. At the moment, the stock has a 52-week-high of $40.82 and a 52-week-low of $7.09. Nuvalent closed at $12.77 at the end of the last trading period.
With a Market Perform rating, BMO Capital initiated coverage on Genmab A/S (NASDAQ:GMAB). The price target seems to have been set at $34.73 for Genmab. Genmab earned $0.11 in the first quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.07 and a 52-week-low of $26.19. Genmab closed at $31.09 at the end of the last trading period.
BMO Capital initiated coverage on Seagen Inc (NASDAQ:SGEN) with a Market Perform rating. The price target for Seagen is set to $169.00. In the first quarter, Seagen showed an EPS of $0.74, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $192.79 and a 52-week-low of $105.43. Seagen closed at $174.00 at the end of the last trading period.
